Хлебные крошки
- Главная
-
Аналитика
-
Акции
Акции внутренные
Assertio Holdings, Inc. ASRT
$7.76
+$0.1 (1.31%)
На 18:01, 12 мая 2023
Ранг: 1
Ключевые показатели
-
Marketcap
436408112.00000000
-
week52high
8.01
-
week52low
2.07
-
Revenue
156234000
-
P/E TTM
3
-
Beta
1.40103800
-
EPS
2.04000000
-
Last Dividend
0.00000000
-
Next Earnings Date
09 мая 2023 г. в 20:00
Описание компании
Assertio Holdings, Inc., a specialty pharmaceutical company, provides medicines in the areas of neurology, hospital, and pain and inflammation. Its pharmaceutical products include INDOCIN, an oral solution and a suppository form for the treatment of moderate to severe rheumatoid arthritis, including acute flares of chronic disease; ankylosing spondylitis and osteoarthritis; and acute painful shoulder and gouty arthritis. It also provides CAMBIA, a non-steroidal anti-inflammatory drug (NSAID) for the treatment of migraine, nausea, photophobia, and phonophobia; Zipsor, a NSAID for relief of mild to moderate acute pain; SPRIX, a NSAID for the short term management of moderate to moderately severe pain that requires analgesia at the opioid level; and Otrexup, a single-dose auto-injector containing a prescription medicine and methotrexate that is used to treat adults with severe, active rheumatoid arthritis, and children with active polyarticular juvenile idiopathic arthritis. The company was formerly known as Assertio Therapeutics, Inc. and changed its name to Assertio Holdings, Inc. in May 2020. Assertio Holdings, Inc. was incorporated in 1995 and is headquartered in Lake Forest, Illinois.
Рекомендации
аналитиков
Рекомендации аналитиков
| Grading company | New grade | Previous grade | Recommendation date |
|---|---|---|---|
| BWS Financial | Buy | 18 мая 2022 г. | |
| Gabelli & Co. | Buy | Hold | 09 апр 2021 г. |
| Brookline Capital | Buy | 25 ноя 2020 г. | |
| Brookline Capital | Buy | 03 июн 2020 г. | |
| Mizuho | Neutral | Neutral | 30 ноя 2018 г. |
| Lake Street | Buy | 07 ноя 2022 г. |
Свежие комментарии
Свежие комментарии
Оставьте свой голос
Оставьте свой голос
Анонимное голосование
Будет ли рост российского рынка к концу года?
-
Да
87% -
Нет
12%
Проголосовал 8 человек
Новостная лента
компании
Insider Summary
Insider Summary
| Reporting Name | Acquistion/Disposition | Owned | Transacted | Transaction Date |
|---|---|---|---|---|
| Schlessinger Sam | D | 38808 | 19404 | 01 окт 2022 г. |
| Schlessinger Sam | D | 33597 | 7205 | 01 окт 2022 г. |
| Schlessinger Sam | A | 40802 | 19404 | 01 окт 2022 г. |
| Schlessinger Sam | D | 7135 | 7135 | 05 авг 2022 г. |
| Schlessinger Sam | D | 21398 | 2369 | 05 авг 2022 г. |
| Schlessinger Sam | A | 23767 | 7135 | 05 авг 2022 г. |
| Patel Ajay | D | 0 | 8060 | 31 июл 2022 г. |
| Patel Ajay | D | 57681 | 3157 | 31 июл 2022 г. |
| Patel Ajay | A | 60838 | 8060 | 31 июл 2022 г. |
| Tyree James L | D | 210451 | 44643 | 12 мая 2022 г. |
Новостная лента
Assertio Holdings, Inc. (ASRT) Q1 2023 Earnings Call Transcript
Seeking Alpha
09 мая 2023 г. в 23:04
Assertio Holdings, Inc. (NASDAQ:ASRT ) Q1 2023 Results Earnings Conference Call May 10, 2023 4:30 PM ET Company Participants Matt Kreps - Darrow Associates, Investor Relations Dan Peisert - President and Chief Executive Officer Paul Schwichtenberg - Senior Vice President and Chief Financial Officer Conference Call Participants Thomas Flaten - Lake Street Capital Markets Scott Henry - ROTH Capital William Wood - B. Riley Securities Hamed Khorsand - BWS Financial Mitra Ramgopal - Sidoti & Company Operator Good afternoon and welcome to the Assertio Holdings, Inc. First Quarter 2023 Financial Results Conference Call.
Artificial Intelligence Engine Predicts ASRT Stock to Gain 3% by June 1
InvestorPlace
04 мая 2023 г. в 10:54
The world's foremost artificial intelligence stock trading algorithm, An-E, predicts that Assertio (NASDAQ: ASRT ) stock will gain 3% by June 1. An-E (pronounced Annie) has made this kind of prediction before.
Assertio Holdings Stock Is Still A Cheap Buy
Seeking Alpha
02 мая 2023 г. в 10:18
Assertio Holdings stock has fallen 8.15% since my updated bullish thesis in March 2023, while the S&P 500 Index has gained 4.95% over the same period. The SPPI deal is expected to give Assertio access to Rolvedon and be accretive to adjusted EPS and operating cash flow in FY2024.
Assertio Holdings, Inc. to Report First Quarter 2023 Financial Results on Tuesday, May 9, 2023
GlobeNewsWire
27 апр 2023 г. в 09:00
LAKE FOREST, Ill., April 27, 2023 (GLOBE NEWSWIRE) -- Assertio Holdings, Inc. (“Assertio” or the “Company”) (Nasdaq: ASRT), a specialty pharmaceutical company offering differentiated products to patients, today announced that it will release first quarter 2023 financial results on Tuesday, May 9, 2023, after the market close. Following the release of its financial results, Assertio's management will host a live webcast of the earnings conference call at 4:30 p.m. Eastern Time.
Spectrum Pharmaceuticals stock pops after Assertio acquires it at a premium
Proactive Investors
25 апр 2023 г. в 11:51
Spectrum Pharmaceuticals (NASDAQ:SPPI) stock is soaring after an all-stock acquisition deal with Assertio Holdings was announced Tuesday morning. The $248 million purchase price values Spectrum shares at $1.14 each, a significant premium over its Tuesday closing price of $0.69.